MedPath

Assessment of Patients' Pain and Anxiety During a Hysterosalpingography Narratified by a Virtual Reality Helmet (Daphné)

Not Applicable
Completed
Conditions
Salpingography
Pain
Anxiety
Virtual Reality
Virtual Reality Exposure Therapy
Interventions
Device: Virtual reality
Registration Number
NCT05036772
Lead Sponsor
Poitiers University Hospital
Brief Summary

Compare the maximum pain and anxiety experienced between the group using a virtual reality headset and the control group in an adult woman during a hysterosalpingography examination

Detailed Description

In France, 1 couples out of 5 consults for suspected infertility. Hysterosalpingography is the first line diagnostic examination in this course and can sometimes be therapeutic. This gynecological examination is invasive in nature, this exam requires an administration of iodinated contrast product by the endocavitary route.

Hysterosalpingography is the most painful examination in this treatment path and pain's assessment is classified as strong by the French National Authority for Health (Haute Autérité de Santé) and anxiety-inducing. For these patients, drug analgesic treatments remain ineffective or contraindicated in outpatient mode. Ionizing irradiation is a constraint that makes hypnosis unsuitable.

Several studies show the contribution of a virtual reality headset in reducing pain and anxiety by inducing patients in an hypnotic environment. This tool standardizes interventions based on changes in consciousness. It is an easy-to-use, non-drug analgesia with few side effects and inexpensive.

The environment offered by this medical device is based on evidence to peacefully escort patients on a journey of natural elements. Calm music is made up of key elements of musical therapy. A medical anesthesiologist and hypnotherapist wrote the hypnotic induction. And, the voice is the one of an experienced sociologist in practice. A simple meditation modeled on heart synchronization sets a persistent goal during this immersion.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • patients over 18 years old
  • patients with a prescription for hysterosalpingography
  • patients able to answer the questionnaire independently (French-speaking or understanding French)
  • informed consent, signed by the patient
  • patients benefiting from a social security scheme or benefiting through a third party
Exclusion Criteria
  • patients with a contraindication to virtual reality headset.
  • refusal to participate in the study
  • Contraindication to the realization of hysterosalpingography (pregnancy / lactation or infection)
  • patient under guardianship, curatorship or subordination

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionnalVirtual realityThe experimental arm will have the possibility to use a distracting virutel environment for the duration of hysterosalpingography.
Primary Outcome Measures
NameTimeMethod
visual analog scale (EVA)through study completion, an average of 1 year

The patient rates her pain level between 0 and 10. The standard question is: "From 0 to 10, with 0 absence of pain and 10 maximum pain, how much will you rate the maximum pain experienced during your examination?"

Secondary Outcome Measures
NameTimeMethod
- Cybersickness evaluationthrough study completion, an average of 1 year

simplified Virtual Reality Sickness Questionnaire (VRSQ) cybersickness scale. (Questionnaire in 9 items)

Dosimetrythrough study completion, an average of 1 year

Collection of the dose report produced surface in mGy.cm²

Time of examthrough study completion, an average of 1 year

Measurement of the time in minutes between the first shot and the last shot (the late evacuation shot will not be taken into account)

anxiety assessmentthrough study completion, an average of 1 year

State Trait Inventory Anxiety (STAI Y-A) anxiety assessment questionnaire

Trial Locations

Locations (1)

Centre Hospitalier Universitaire

🇫🇷

Poitiers, France

© Copyright 2025. All Rights Reserved by MedPath